R
Robert C. Moellering
Researcher at Beth Israel Deaconess Medical Center
Publications - 297
Citations - 24622
Robert C. Moellering is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Antibiotics & Vancomycin. The author has an hindex of 83, co-authored 297 publications receiving 23781 citations. Previous affiliations of Robert C. Moellering include Harvard University & Deaconess Hospital.
Papers
More filters
Journal ArticleDOI
Lack of Bactericidal Antagonism or Synergism In Vitro between Oxacillin and Vancomycin against Methicillin-Susceptible Strains of Staphylococcus aureus
Christian Joukhadar,Satish K. Pillai,Satish K. Pillai,Christine Wennersten,Robert C. Moellering,Robert C. Moellering,George M. Eliopoulos,George M. Eliopoulos +7 more
TL;DR: There was no evidence that vancomycin antagonized the bactericidal effect of oxacillin or that there was any benefit from use of the combination, and a dynamic model simulation found the time-kill profiles of these regimens against S. aureus infections were comparable to those observed in the fixed-concentration experiments.
Journal ArticleDOI
Molecular Characterization of Vancomycin-Resistant Enterococci Repopulating the Gastrointestinal Tract following Treatment with a Novel Glycolipodepsipeptide, Ramoplanin
Lindsey R. Baden,I. A. Critchley,D. F. Sahm,W. So,M. Gedde,S. Porter,Robert C. Moellering,George M. Eliopoulos +7 more
TL;DR: Stool isolates recovered during a phase II trial of ramoplanin for the treatment of patients with stool carriage of vancomycin-resistant enterococci had a relapse caused by a genotypically related isolate, and antibiotics with activities against anaerobic organisms were associated with positive cultures.
Journal ArticleDOI
Therapeutic Potential of Rifampin in Enterococcal Infections
TL;DR: Limited data from studies done in vivo are contradictory and do not document unequivocally that rifampin is strikingly active, even in combination with other agents, against enterococcal infections in humans.
Journal ArticleDOI
A 39-year-old man with a skin infection.
TL;DR: The case of Mr M, a previously healthy 39-year-old man with erythema and swelling of his finger, illustrates the issues involved in treating community-acquired skin and soft tissue infections since the emergence of methicillin-resistant Staphylococcus aureus (MRSA) in the community.
Journal ArticleDOI
Common adverse effects of antibacterial agents on major organ systems.
TL;DR: The major adverse reactions to antibiotics are reviewed so that side effects may be promptly recognized and treated and the surgeon can more effectively utilize this valuable class of drugs for the benefit of the patient.